BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 21144578)

  • 1. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
    Rothwell PM; Fowkes FG; Belch JF; Ogawa H; Warlow CP; Meade TW
    Lancet; 2011 Jan; 377(9759):31-41. PubMed ID: 21144578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
    Rothwell PM; Wilson M; Price JF; Belch JF; Meade TW; Mehta Z
    Lancet; 2012 Apr; 379(9826):1591-601. PubMed ID: 22440947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
    Rothwell PM; Wilson M; Elwin CE; Norrving B; Algra A; Warlow CP; Meade TW
    Lancet; 2010 Nov; 376(9754):1741-50. PubMed ID: 20970847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
    Rothwell PM; Price JF; Fowkes FG; Zanchetti A; Roncaglioni MC; Tognoni G; Lee R; Belch JF; Wilson M; Mehta Z; Meade TW
    Lancet; 2012 Apr; 379(9826):1602-12. PubMed ID: 22440946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
    Algra AM; Rothwell PM
    Lancet Oncol; 2012 May; 13(5):518-27. PubMed ID: 22440112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Rothwell PM; Cook NR; Gaziano JM; Price JF; Belch JFF; Roncaglioni MC; Morimoto T; Mehta Z
    Lancet; 2018 Aug; 392(10145):387-399. PubMed ID: 30017552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
    Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
    Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
    Joharatnam-Hogan N; Cafferty F; Hubner R; Swinson D; Sothi S; Gupta K; Falk S; Patel K; Warner N; Kunene V; Rowley S; Khabra K; Underwood T; Jankowski J; Bridgewater J; Crossley A; Henson V; Berkman L; Gilbert D; Kynaston H; Ring A; Cameron D; Din F; Graham J; Iveson T; Adams R; Thomas A; Wilson R; Pramesh CS; Langley R;
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):854-862. PubMed ID: 31477558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
    Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
    Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials.
    Mills EJ; Wu P; Alberton M; Kanters S; Lanas A; Lester R
    Am J Med; 2012 Jun; 125(6):560-7. PubMed ID: 22513195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancers prevented in Australia in 2010 through the consumption of aspirin.
    Wilson LF; Green AC; Kendall BJ; Jordan SJ; Nagle CM; Bain CJ; Neale RE; Whiteman DC
    Aust N Z J Public Health; 2015 Oct; 39(5):414-7. PubMed ID: 26437724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
    Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
    van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
    Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.